Mainstreet Health Investments Inc. announces closing of over-allotment option
/NOT FOR DISTRIBUTION TO THE U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/
TORONTO, JUNE 21, 2016 – Mainstreet Health Investments Inc. (the “Corporation” or “Mainstreet”) (TSX: HLP.U) announced today the issuance of an additional 1,425,000 common shares of the Corporation at a price of US$10.00 per share for gross proceeds of US$14,250,000. The issuance was pursuant to the exercise of an over-allotment option granted to a syndicate of underwriters led by BMO Capital Markets, CIBC Capital Markets and National Bank Financial Inc. in connection with the Corporation’s recent public offering (the “Offering”). The issuance of shares pursuant to the exercise of the over-allotment option increases the total gross proceeds of the Offering to US$109,250,000.
The net proceeds to the Corporation from the exercise of the over-allotment option will be used by the Corporation for working capital purposes.
The securities offered pursuant to the Offering have not and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any U.S. State securities laws and may not be offered or sold, directly or indirectly, within the United States or its territories or possessions or to or for the account of any U.S. person (as defined in Regulation S under the U.S. Securities Act) other than pursuant to an available exemption from the registration requirements of the U.S. Securities Act and in compliance with U.S. State securities laws. This press release does not constitute an offer to sell or a solicitation of an offer to buy any such securities within the United States, or its territories or possessions, or to or for the account of any U.S. person.
About Mainstreet Health Investments Inc.
Mainstreet Health Investments Inc. acquires the highest-quality healthcare properties in North America with the intention to create long-term shareholder value. Partnering with best-in-class healthcare providers, these partnerships serve the healthcare consumer while providing an investment opportunity that matters. For more information, visit www.mainstreethealthinvestments.com.
Caution Regarding Forward Looking Information
This press release may contain forward-looking statements which reflect management’s current expectations regarding future events, including those relating to the Offering and the use of proceeds from the exercise of the over-allotment option. The forward-looking statements involve risks and uncertainties. Actual results could differ materially from those projected herein. Readers are cautioned not to place undue reliance on this forward-looking information, which is given as of the date hereof, and to not use such forward looking information for anything other than its intended purpose. Mainstreet undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.
SOURCE Mainstreet Health Investments Inc.
For further information: Investors: Mr. Randy Henry, Director – Investor Relations, 1-317-582-6971, rhenry@maininvest.com; Media: Ms. Ashley Mattox, Communications Manager, amattox@maininvest.com